Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Aug 01, 2020
TickeronGET DAILY SIGNALS
Life Insurers are Limping in to Their Earnings Reports, and the Fundamentals Aren’t Good

Life Insurers are Limping in to Their Earnings Reports, and the Fundamentals Aren’t Good

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured. Policies may be sold as term life which assures payment of a stated death benefit, but expires at the end of a specified term. They can also be sold as permanent or whole life policies. These policies are more expensive, but lasts a lifetime and carry a cash accumulation component. Life insurance firms may also sell long-term disability policies that help to replace the insured’s income if they become sick or disabled.

Over the last week the life insurance group has been one of the worst performing groups in terms of stock returns. We see on Tickeron’s Group Trends Screener that it’s within the worst seven performers with a loss of 3.19%. This probably isn’t what investors want to see with a number of members of the group getting ready to report earnings next week.

Prudential Financial (PRU) will report earnings on August 4. Manulife Financial (MFC) and Metlife (MET) will both report on August 5. Looking at a comparison of these three companies and their fundamental indicators, there isn’t much to be excited about.

All three companies get positive ratings for being undervalued, but the only other positive rating for any of them is a the outlook rating for Prudential. All of the other ratings are either neutral or negative. There are seven different categories and that gives us a total of 21 indicators. Out of 21 indicators, only four are positive. That’s not a very good percentage.

Personally I find it very concerning that all three stocks get the worst possible scores on the Profit Vs. Risk rating and the SMR rating. That is a major red flag for me when it comes to the long-term prospects for the stocks. Tickeron has a negative outlook on this group and predicts a further decline by more than 4.00% within the next month with a likelihood of 65%.

The technical analysis looks considerably better. You should keep in mind though that technical analysis tends to be more useful over the short-term. Tickeron’s technical analysis screener shows Metlife with five positive ratings and only one negative rating.

Prudential has four positive ratings and only two negative ratings. Manulife has only one positive rating and one negative rating.

The earnings estimates and the sentiment indicators for the three companies are very different in some areas and very similar in other areas. Metlife and Prudential have seen their consensus estimate get cut rather drastically over the last 90 days. For Metlife the EPS estimate was at $1.32 three months ago and is now at $0.90. Prudential’s EPS estimate was $2.65 and it’s now $1.71. Those are cuts of 31.8% and 35.5% respectively. We see that both of the companies are expected to earn considerably less than they did in the same period of 2019.

Manulife’s numbers are very different. We see that EPS estimate has been bumped up slightly, from $0.47 to $0.50, and the company is expected to earn more than it did last year.

As for the sentiment indicators, analysts have similar ratings on Metlife and Manulife with both buy percentages at 64%. Analysts are considerably more bearish on Prudential with a buy percentage of only 20%. Short sellers share a similar opinion with the short interest ratios for Metlife and Manulife in the same range while Prudential’s is higher.

The Tickeron Scorecard for these three stocks shows Metlife and Prudential each have “buy” ratings while Manulife has a “sell” rating. Those ratings are based primarily on the short-term outlook and the technical indicators. From a longer term perspective, I feel Manulife has the better outlook.

 

Related Ticker: PRU

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


PRU's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for PRU moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In 23 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRU as a result. In 52 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for PRU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 26 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

PRU broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

PRU moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PRU crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +3.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRU advanced for three days, in 210 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

The Aroon Indicator entered an Uptrend today. In 177 of 313 cases where PRU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 30 (best 1 - 100 worst), indicating outstanding price growth. PRU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.303) is normal, around the industry mean (1.337). P/E Ratio (10.752) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.674) is also within normal values, averaging (0.463). Dividend Yield (0.047) settles around the average of (0.047) among similar stocks. P/S Ratio (0.632) is also within normal values, averaging (1.303).

The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are MetLife (NYSE:MET), Prudential Financial (NYSE:PRU), Lincoln National Corp (NYSE:LNC), Genworth Financial (NYSE:GNW).

Industry description

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Life/Health Insurance Industry is 18.5B. The market cap for tickers in the group ranges from 228.36K to 140.68B. CILJF holds the highest valuation in this group at 140.68B. The lowest valued company is GWGHQ at 228.36K.

High and low price notable news

The average weekly price growth across all stocks in the Life/Health Insurance Industry was -7%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -9%. SNFCA experienced the highest price growth at 0%, while ABX experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Life/Health Insurance Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 24% and the average quarterly volume growth was 50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 65
Price Growth Rating: 56
SMR Rating: 91
Profit Risk Rating: 61
Seasonality Score: 9 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry LifeHealthInsurance

Industry
Financial Conglomerates
Address
751 Broad Street
Phone
+1 973 802-6000
Employees
36824
Web
https://www.prudential.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.